Warning: Parameter 2 to flowplayer3_swftools_flashvars() expected to be a reference, value given in module_invoke() (line 476 of /var/www/pressflow/includes/module.inc).
The FDA today withdrew the Parkinson's disease drug pergolide -- a dopamine agonist sold as Permax and as a generic -- because of an increased risk of valvular heart disease. Continue reading ⇒
The U.S. Food and Drug Administration (FDA) today announced that manufacturers of pergolide drug products, which are used to treat Parkinson’s disease, will voluntarily remove these drugs from the market because of the risk of serious damage to patients’ heart valves. Continue reading ⇒
